Matches in SemOpenAlex for { <https://semopenalex.org/work/W2351849798> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2351849798 endingPage "e266" @default.
- W2351849798 startingPage "e266" @default.
- W2351849798 abstract "To identify predictive factors for receiving fertility preservation treatment among female pediatric patients. Retrospective analysis. We performed an analysis of female pediatric patients seen for fertility preservation consultation at an academic fertility center prior to gonadotoxic treatment from 2002-2014. Multivariate logistic regression models were constructed to identify factors associated with receiving fertility preservation treatment. Adjusted odds ratios (OR) with 95%confidence intervals (CI) were calculated. Over 12 years, 102 females ages 6-21 years old were seen for fertility preservation consultation with a mean age of 16.7 years old; 14.7% were prepubertal. Diagnoses included the following malignancies: hematologic (61.8%, n=63), neurologic (10.8%, n=11), orthopedic tumors or sarcomas (9.8%, n=10), ovarian (8.8%, n=9) and gastrointestinal (4.9%, n=5). Remaining patients had medical conditions requiring gonadotoxic treatment (3.9%, n=4). Of those seen for consultation, 25.5% (n=26 pursued fertility preservation. The most utilized treatment modality was ovarian tissue cryopreservation (65.4%, n=17) followed by oocyte cryopreservation (34.6%, n=9). In comparing patients who pursued ovarian tissue cryopreservation and oocyte cryopreservation, there was no significant difference in age or pubertal status. After adjustment, a history of prior chemotherapy was associated with decreased odds of receiving fertility preservation treatment (OR=0.03, 95% CI 0.01-0.04). Age, race, pubertal status and type of cancer were not statistically associated with odds of receiving fertility preservation treatment. Ovarian tissue cryopreservation emerged as the most utilized fertility preservation treatment modality in this patient population. Future work is needed to investigate techniques to use cryopreserved ovarian tissue for fertility for this group as they reach adulthood. The finding that prior chemotherapy is negatively associated with fertility preservation in pediatric patients undergoing gonadotoxic chemotherapy underscores the importance of earlier referral and education regarding fertility preservation in newly diagnosed pediatric cancer patients." @default.
- W2351849798 created "2016-06-24" @default.
- W2351849798 creator A5038226342 @default.
- W2351849798 creator A5045390680 @default.
- W2351849798 creator A5046316074 @default.
- W2351849798 creator A5051555660 @default.
- W2351849798 creator A5063648770 @default.
- W2351849798 creator A5085679141 @default.
- W2351849798 date "2015-09-01" @default.
- W2351849798 modified "2023-10-18" @default.
- W2351849798 title "Fertility preservation in female pediatric patients prior to gonadotoxic therapy: predictive factors for receiving fertility preservation treatment" @default.
- W2351849798 doi "https://doi.org/10.1016/j.fertnstert.2015.07.835" @default.
- W2351849798 hasPublicationYear "2015" @default.
- W2351849798 type Work @default.
- W2351849798 sameAs 2351849798 @default.
- W2351849798 citedByCount "0" @default.
- W2351849798 crossrefType "journal-article" @default.
- W2351849798 hasAuthorship W2351849798A5038226342 @default.
- W2351849798 hasAuthorship W2351849798A5045390680 @default.
- W2351849798 hasAuthorship W2351849798A5046316074 @default.
- W2351849798 hasAuthorship W2351849798A5051555660 @default.
- W2351849798 hasAuthorship W2351849798A5063648770 @default.
- W2351849798 hasAuthorship W2351849798A5085679141 @default.
- W2351849798 hasBestOaLocation W23518497981 @default.
- W2351849798 hasConcept C126322002 @default.
- W2351849798 hasConcept C156957248 @default.
- W2351849798 hasConcept C18597862 @default.
- W2351849798 hasConcept C205545832 @default.
- W2351849798 hasConcept C2777904497 @default.
- W2351849798 hasConcept C2778459216 @default.
- W2351849798 hasConcept C2908647359 @default.
- W2351849798 hasConcept C29456083 @default.
- W2351849798 hasConcept C518429986 @default.
- W2351849798 hasConcept C71924100 @default.
- W2351849798 hasConcept C99454951 @default.
- W2351849798 hasConceptScore W2351849798C126322002 @default.
- W2351849798 hasConceptScore W2351849798C156957248 @default.
- W2351849798 hasConceptScore W2351849798C18597862 @default.
- W2351849798 hasConceptScore W2351849798C205545832 @default.
- W2351849798 hasConceptScore W2351849798C2777904497 @default.
- W2351849798 hasConceptScore W2351849798C2778459216 @default.
- W2351849798 hasConceptScore W2351849798C2908647359 @default.
- W2351849798 hasConceptScore W2351849798C29456083 @default.
- W2351849798 hasConceptScore W2351849798C518429986 @default.
- W2351849798 hasConceptScore W2351849798C71924100 @default.
- W2351849798 hasConceptScore W2351849798C99454951 @default.
- W2351849798 hasIssue "3" @default.
- W2351849798 hasLocation W23518497981 @default.
- W2351849798 hasOpenAccess W2351849798 @default.
- W2351849798 hasPrimaryLocation W23518497981 @default.
- W2351849798 hasRelatedWork W1898832739 @default.
- W2351849798 hasRelatedWork W2155118448 @default.
- W2351849798 hasRelatedWork W2321844316 @default.
- W2351849798 hasRelatedWork W2413569429 @default.
- W2351849798 hasRelatedWork W2474076206 @default.
- W2351849798 hasRelatedWork W2507147169 @default.
- W2351849798 hasRelatedWork W2920537992 @default.
- W2351849798 hasRelatedWork W3029786921 @default.
- W2351849798 hasRelatedWork W4318696255 @default.
- W2351849798 hasRelatedWork W86666168 @default.
- W2351849798 hasVolume "104" @default.
- W2351849798 isParatext "false" @default.
- W2351849798 isRetracted "false" @default.
- W2351849798 magId "2351849798" @default.
- W2351849798 workType "article" @default.